HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability

Isaacs, Jennifer S., Jung, Yun Jin, Mole, David R., Lee, Sunmin, Torres-Cabala, Carlos, Chung, Yuen-Li, Merino, Maria, Trepel, Jane, Zbar, Berton, Toro, Jorge, Ratcliffe, Peter J., Linehan, W. Marston, Neckers, Len·2005·Cancer Cell
DOI 10.1016/j.ccr.2005.06.017

Cited by (957)

Items 601–700 of 957

  1. The deep end of the metabolite pool: influences on epigenetic regulatory mechanisms in cancer
    Kendra K. S. Nordgren, Andrew J. Skildum · 2014 · European Journal of Clinical Investigation
  2. Hereditary renal cell carcinoma: genetics, clinical features, and surgical considerations
    Timothy K. Byler, Gennady Bratslavsky · 2014 · World Journal of Urology
  3. Lipophilic modification enhances anti-colitic properties of rosmarinic acid by potentiating its HIF-prolyl hydroxylases inhibitory activity
    Seongkeun Jeong, Huijeong Park, Sungchae Hong, Soohwan Yum, Wooseong Kim, Yunjin Jung · 2014 · European Journal of Pharmacology
  4. Molecular basis for the treatment of renal cell carcinoma
    Cristina Suárez, Rafael Morales‐Barrera, Eva Muñoz‐Couselo, Jordi Ahnert Rodon, Claudia María Valverde, Joan Carles · 2010 · Clinical & Translational Oncology
  5. Non–Clear Cell Renal Cell Carcinoma: How New Biological Insight May Lead to New Therapeutic Modalities
    Axel Bex, James Larkin, Christian U. Blank · 2011 · Current Oncology Reports
  6. Surgical Management of von Hippel-Lindau Disease: Urologic Considerations
    Amanda Beth Reed, Dipen J. Parekh · 2008 · Surgical Oncology Clinics of North America
  7. Seeing the smoking gun: a sensitive and specific method to visualize loss of the tumour suppressor, fumarate hydratase, in human tissues
    Patrick Henry Maxwell · 2011 · The Journal of Pathology
  8. One-month assessment of renal cell carcinoma treated by everolimus using FDG PET/CT predicts progression-free and overall survival
    Hiroki Ito, Keiichi Kondo, Takashi Kawahara, Tomohiro Kaneta, Ukihide Tateishi, Daiki Ueno, Kazuhiro Namura, Kazuki Kobayashi, Yasuhide Miyoshi, Yasushi Yumura et al. · 2017 · Cancer Chemotherapy and Pharmacology
  9. Hypoxic Adaptation in the Nervous System: Promise for Novel Therapeutics for Acute and Chronic Neurodegeneration
    Rachel E. Speer, Rajiv R. Ratan · 2016 · Advances in experimental medicine and biology
  10. Downregulation of Fumarate Hydratase Is Related to Tumorigenesis in Sporadic Renal Cell Cancer
    Yun‐Sok Ha, Yoshitomo Chihara, Hyung-Yoon Yoon, Yong‐June Kim, Tae-Hwan Kim, Seung Hyo Woo, Seok Joong Yun, Isaac Yi Kim, Yoshihiko Hirao, Wun‐Jae Kim · 2012 · Urologia Internationalis
  11. Targeting NAD+ Metabolism Vulnerability in FH-Deficient Hereditary Leiomyomatosis and Renal Cell Carcinoma with the Novel NAMPT Inhibitor OT-82
    Susana Sarai Najera, Christopher J. Ricketts, Laura S. Schmidt, Julia I. Medina, Keita Saito, Lilia V. Ileva, Jeffrey Brender, Amy E. James, Cody J. Peer, Brad A. Gouker et al. · 2024 · Molecular Cancer Therapeutics
  12. Nuclear functional role of metabolic enzymes and related metabolites: Focus on gene expression regulation
    Simona Todisco, Dominga Iacobazzi, Anna Santarsiero, Paolo Convertini, Vittoria Infantino · 2025 · Molecular Metabolism
  13. Identification of SPOP related metabolic pathways in prostate cancer
    Min Yan, Huan Qi, Jia Li, Guozhu Ye, Yaping Shao, Tongming Li, Jing Liu, Hai‐long Piao, Guowang Xu · 2017 · Oncotarget
  14. Identification of key genes and functional enrichment pathways involved in fat deposition in Xinyang buffalo by WGCNA
    Shuzhe Wang, Chaoyun Yang, Cuili Pan, Xue Feng, Zhaoxiong Lei, Jieping Huang, Xuefeng Wei, Fen li, Yun Ma · 2022 · Gene
  15. Functional Imaging Experience in a Germline Fumarate Hydratase Mutation–Positive Patient With Pheochromocytoma and Paraganglioma
    Joan Nambuba, Roland Därr, Ingo Janssen, Petra Bullova, Karen T. Adams, Corina Millo, Isabelle Bourdeau, Andrea Kassai, Chunzhang Yang, Electron Kebebew et al. · 2015 · AACE Clinical Case Reports
  16. The Function of Hypoxia-Inducible Factor (HIF) Is Independent of the Endoplasmic Reticulum Protein OS-9
    Ulf Brockmeier, Corinna Platzek, Kirsten Schneider, Pauline Patak, André Bernardini, Joachim Fandrey, Eric Metzen · 2011 · PLoS ONE
  17. Family Cancer Syndromes
    Helga Rehder · 2008 · Wiley eBooks
  18. Emerging roles of metabolic biomarkers in renal cell carcinoma: from molecular mechanisms to clinical implications
    Junkai Yang, Daojia Miao, Xinwei Li, Chuanyi Zhao, Diaoyi Tan, Songming Wu, Feiyi Lu, Jian Shi, Qingyang Lv, Hailong Ruan et al. · 2025 · Frontiers in Cell and Developmental Biology
  19. Mitochondria act as a key regulatory factor in cancer progression: Current concepts on mutations, mitochondrial dynamics, and therapeutic approach
    Sraddhya Roy, Ananya Das, Aparajita Bairagi, Debangshi Das, Ashna Jha, Amit Kumar Srivastava, Nabanita Chatterjee · 2024 · Mutation Research/Reviews in Mutation Research
  20. Metabolic priming by multiple enzyme systems supports glycolysis, HIF1α stabilisation, and human cancer cell survival in early hypoxia
    Fiona Grimm, Agustín Asuaje, Aakriti Jain, Mariana Silva dos Santos, Jens Kleinjung, Patrícia M. Nunes, Stefanie M. Gehrig, Louise Fets, Salihanur Darici, James I. MacRae et al. · 2024 · The EMBO Journal
  21. Tolerance of DNA Replication Stress Is Promoted by Fumarate Through Modulation of Histone Demethylation and Enhancement of Replicative Intermediate Processing inSaccharomyces cerevisiae
    Faeze Saatchi, Ann L. Kirchmaier · 2019 · Genetics
  22. Pathology of Renal Cell Carcinoma
    Ming Zhou, Huiying He · 2012 · Humana Press eBooks
  23. Protein Profiling of Blood Samples from Patients with Hereditary Leiomyomatosis and Renal Cell Cancer by Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry
    Takao Kamai, Naohisa Tomosugi, Hideyuki Abe, Yasushi Kaji, Tetsunari Oyama, Ken‐Ichiro Yoshida · 2012 · International Journal of Molecular Sciences
  24. Abnormal Cystic Tumor in a Patient with Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome: Evidence of a Precursor Lesion?
    Benjamin T. Ristau, Sonal N. Kamat, Tatum V. Tarin · 2015 · Case Reports in Urology
  25. Fumarase tumor suppressor gene and MET oncogene cooperate in upholding transformation and tumorigenesis
    Barbara Costa, Daniela Dettori, Annalisa Lorenzato, Chiara Bardella, Nadia Coltella, Cosimo Martino, Cristina Cammarata, Peter Carmeliet, Martina Olivero, Maria Flavia Di Renzo · 2010 · The FASEB Journal
  26. Hypoxia-Induced Downregulation of miR-29 in Renal Tumor Cells Affects Collagen IV Subunit Expression through Multiple Sites
    Chuncheng Liu, Linan Liu, Jinlai Bo, Xian Cai Lu, Donghui Qu, Gehui Liu, Zhiyan Jiang, Lu Cai · 2022 · Biomedicines
  27. Oxygen-independent stabilization of HIF-2α in breast cancer through direct interaction with peptidyl-prolyl cis-trans isomerase NIMA-interacting 1
    Yanymee N. Guillen Quispe, Su‐Jung Kim, Soma Saeidi, Tianchi Zhou, Jie Zheng, Seong Hoon Kim, Xizhu Fang, Chaithanya Chelakkot, Milton E. Rios-Castillo, Young Kee Shin et al. · 2023 · Free Radical Biology and Medicine
  28. Targeting EGLN2/PHD1 protects motor neurons and normalizes the astrocytic interferon response
    Christine Germeys, Tijs Vandoorne, Kristofer Davie, Suresh Kumar Poovathingal, Kara Heeren, Wendy Vermeire, Fatemeharefeh Nami, Matthieu Moisse, Annelies Quaegebeur, Annerieke S. R. Sierksma et al. · 2024 · Cell Reports
  29. Management of renal cell carcinoma in young patients and patients with hereditary syndromes
    Cynthia Leung, Shu Pan, Brian M. Shuch · 2016 · Current Opinion in Urology
  30. Direct and quantitative analysis of altered metabolic flux distributions and cellular ATP production pathway in fumarate hydratase-diminished cells
    Shingo Noguchi, Hirokazu Ishikawa, Kenichi Wakita, Fumio Matsuda, Hiroshi Shimizu · 2020 · Scientific Reports
  31. Mitochondrial Tumor Suppressors—The Energetic Enemies of Tumor Progression
    Pavel Jakoubě, Valentina Cutano, Juan M. González-Morena, Zuzana Keckesova · 2021 · Cancer Research
  32. Reduced expression of mitochondrial fumarate hydratase in progressive multiple sclerosis contributes to impaired in vitro mesenchymal stromal cell-mediated neuroprotection
    Pamela Sarkar, Juliana Redondo, Kelly M Hares, Stephen H. Bailey, Anastasia Georgievskaya, Kate J. Heesom, Kevin C. Kemp, Neil J. Scolding, Claire M Rice · 2021 · Multiple Sclerosis Journal
  33. Fumarate hydratase inhibits non‑small cell lung cancer metastasis via inactivation of AMPK and upregulation of DAB2
    Anupama Vadhan, Yi‐Fang Yang, Yun‐Ming Wang, Pang‐Yu Chen, Shey-Cherng Tzou, Kuang‐Hung Cheng, Stephen Chu‐Sung Hu, Tian‐Lu Cheng, Yen‐Yun Wang, Shyng‐Shiou F. Yuan · 2022 · Oncology Letters
  34. The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers
    Fiach C. O’Mahony, Jyoti Nanda, Alexander Laird, Peter Mullen, Helen Caldwell, Ian M. Overton, Lél Eöry, Marie O’Donnell, Dana Faratian, Thomas B. Powles et al. · 2013 · Journal of Visualized Experiments
  35. Therapeutic Strategies for Hereditary Kidney Cancer
    Abhinav Sidana, Ramaprasad Srinivasan · 2016 · Current Oncology Reports
  36. Use of antisense oligonucleotides to correct the splicing error in ISCU myopathy patient cell lines
    Gregory P. Holmes‐Hampton, Daniel R. Crooks, Ronald G. Haller, Shuling Guo, Susan M. Freier, Brett P. Monia, Tracey Ann Rouault · 2016 · Human Molecular Genetics
  37. Combined effects of FH (E404D) and ACOX2 (R409H) cause metabolic defects in primary cardiac malignant tumor
    Xiangyu Zhou, Mengjia Xu, Weijia Zeng, Zhongzhong Chen, Guohui Lu, Yun Gong, Richard H. Finnell, Huasheng Xiao, Bin Qiao, Hongyan Wang · 2018 · Cell Death Discovery
  38. Liquid Chromatography Mass Spectrometry-Based Metabolite Pathway Analyses of Myeloma and Non-Hodgkin's Lymphoma Patients.
    Carl Angelo Medriano, Jinhyuk Na, Kyung‐Min Lim, Jin Ho Chung, Youngja H. Park · 2017 · Europe PMC (PubMed Central)
  39. Proteasome inhibition disrupts the metabolism of fumarate hydratase- deficient tumors by downregulating p62 and c-Myc
    Carole Sourbier, Christopher J. Ricketts, Pei‐Jyun Liao, Shingo Matsumoto, Darmood Wei, Martin Lang, Reema S. Railkar, Youfeng Yang, Ming-Hui Wei, Piyush Kumar Agarwal et al. · 2019 · Scientific Reports
  40. Frequent microsatellite instability in primary esophageal carcinoma associated with extraesophageal primary carcinoma
    Naoshi Kubo, Masakazu Yashiro, Masaichi Ohira, Takeshi Hori, Ichiro Fujiwara, Kosei Hirakawa · 2004 · International Journal of Cancer
  41. Pyruvate kinase M2 activation maintains mitochondrial metabolism by regulating the interaction between HIF-1α and PGC-1α in diabetic kidney disease
    Jimin Park, Young Su Joo, Bo Young Nam, Gyuri Kim, Jung Tak Park, Tae‐Hyun Yoo, Shin‐Wook Kang, Seung Hyeok Han · 2025 · Molecular Medicine
  42. The Molecular Role of HIF1α Is Elucidated in Chronic Myeloid Leukemia
    Vivek Kumar Singh, Ranjana Singh, Rashmi Kushwaha, Shailendra Prasad Verma, Anil Kumar Tripathi, Abbas Ali Mahdi · 2022 · Frontiers in Oncology
  43. Urine Tricarboxylic Acid Cycle Metabolites and Risk of End-stage Kidney Disease in Patients With Type 2 Diabetes
    Jianjun Liu, Sylvia Liu, Huili Zheng, Janus Lee, Resham L Gurung, Clara Chan, Lye Siang Lee, Keven Ang, Jianhong Ching, Jean‐Paul Kovalik et al. · 2024 · The Journal of Clinical Endocrinology & Metabolism
  44. Advanced treatments in non-clear renal cell carcinoma.
    El Mehdi Tazi, Ismail Essâdi, Mohamed Fadl Tazi, Youness Ahellal, Hind Mâ€TMRabti, Hassan H Errihani · 2011 · Urology journal./Urology jornal. · Retracted
  45. Identification of metabolic changes leading to cancer susceptibility in Fanconi anemia cells
    Etna Abad, Sara Samino, Robert L. Grodzicki, Giovanni Pagano, Marco Trifuoggi, Dmitry Graifer, David Potěšil, Zbyněk Zdráhal, Óscar Yanes, Alex Lyakhovich · 2020 · Cancer Letters
  46. The pathological and molecular genetic landscape of the hereditary renal cancer predisposition syndromes
    Khaleel I. Al‐Obaidy, Zainab I. Alruwaii, Sean R. Williamson, Liang Cheng C · 2022 · Histopathology
  47. Crosstalk of Epigenetic and Metabolic Signaling Underpinning Glioblastoma Pathogenesis
    Mariam Markouli, Dimitrios Strepkos, Kostas A. Papavassiliou, Athanasios G. Papavassiliou, Christina Piperi · 2022 · Cancers
  48. Sequential treatments in Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC). Case report and review of the literature.
    Guillermo de Velasco, Cesar Munoz, Juan Manuel Sepúlveda-Sánchez, Daniel Castellano · 2015 · Canadian Urological Association Journal
  49. Key pathways and genes controlling the development and progression of clear cell renal cell carcinoma (ccRCC) based on gene set enrichment analysis
    Haipeng Huang, Yanyan Tang, Wenwu He, Qi Huang, Jianing Zhong, Zhanbin Yang · 2013 · International Urology and Nephrology
  50. Pheochromocytoma/Paraganglioma: A Poster Child for Cancer Metabolism
    Sergei G. Tevosian, Hans K. Ghayee · 2018 · The Journal of Clinical Endocrinology & Metabolism
  51. From Metabolism to Genetics and Vice Versa: The Rising Role of Oncometabolites in Cancer Development and Therapy
    Emanuela Di Gregorio, Gianmaria Miolo, Asia Saorin, Agostino Steffan, Giuseppe Corona · 2021 · International Journal of Molecular Sciences
  52. The Metabolic Basis of Kidney Cancer
    Ramaprasad Srinivasan, Arvin Koruthu George, William Marston Linehan · 2015 · Springer eBooks
  53. PHD2Mutation and Congenital Erythrocytosis with Paraganglioma
    Holger K. Eltzschig, Tobias de la Garza Eckle, Almut Grenz · 2009 · New England Journal of Medicine
  54. Metal‐(Acyclic Diaminocarbene) Complexes Demonstrate Nanomolar Antiproliferative Activity against Triple‐Negative Breast Cancer
    Svetlana A. Katkova, Alexander Siyasatovich Bunev, Rovshan Е. Gasanov, Dmitry A. Khochenkov, Andrey V. Kulsha, Олег Анатольевич Ивашкевич, Tatiyana V. Serebryanskaya, Mikhail A. Kinzhalov · 2024 · Chemistry - A European Journal
  55. An Oncometabolite Isomer Rapidly Induces a Pathophysiological Protein Modification
    Sarah E. Bergholtz, Chloe A. Briney, Susana Sarai Najera, Minervo Perez, William Marston Linehan, Jordan L. Meier · 2020 · ACS Chemical Biology
  56. The epigenetic–metabolic interplay in gliomagenesis
    Bismi Phasaludeen, Bright Starling Emerald, Suraiya Anjum Ansari · 2022 · Open Biology
  57. Signalling pathways in succinate dehydrogenase B ‐associated renal carcinoma
    Stewart Fleming, Nick J. Mayer, Ljiljana Vlatkovic, Joanne McLean, Michelle McConachie, David U. Baty · 2013 · Histopathology
  58. Review: Warburg effect and renal cancer caused by errs in fumarate hydratase encoding gene.
    Aminah Suhail Qureshi, Sikander Ali · 2019 · PubMed
  59. Hyperpolarized mitochondria accumulate in Drosophila Hipk-overexpressing cells to drive tumor-like growth
    Kenneth Kin Lam Wong, Jenny Zhe Liao, Claire R. Y. Shih, Nicholas Harden, Esther M. Verheyen · 2020 · Journal of Cell Science
  60. NovelFHmutation in a patient with cutaneous leiomyomatosis associated with cutis verticis gyrata, eruptive collagenoma and Charcot-Marie-Tooth disease
    Myriam Marque, Betty Gardie, Brigitte Bressac–de Paillerets, Pierre Rustin, Bernard Guillot, S. Richard, D. Bessis · 2010 · British Journal of Dermatology
  61. Redox-Related Epigenetic Mechanisms in Glioblastoma: Nuclear Factor (Erythroid-Derived 2)-Like 2, Cobalamin, and Dopamine Receptor Subtype 4
    Matthew Scott Schrier, Malav Suchin Trivedi, Richard C. Deth · 2017 · Frontiers in Oncology
  62. l-2-Hydroxyglutarate remodeling of the epigenome and epitranscriptome creates a metabolic vulnerability in kidney cancer models
    Anirban Kundu, Garrett J. Brinkley, Hyeyoung Nam, Suman Karki, Richard L. Kirkman, Madhuparna Pandit, Eun‐Hee Shim, Hayley Widden, Juan Liu, Yasaman Heidarian et al. · 2024 · Journal of Clinical Investigation
  63. Tricarboxylic Acid Cycle Relationships with Non-Metabolic Processes: A Short Story with DNA Repair and Its Consequences on Cancer Therapy Resistance
    Enol Álvarez-González, Luisa María Sierra · 2024 · International Journal of Molecular Sciences
  64. Inference of cancer mechanisms through computational systems analysis
    Zhen Qi, Eberhard O. Voit · 2017 · Molecular BioSystems
  65. CEA: Combination-based gene set functional enrichment analysis
    Duanchen Sun, Yinliang Liu, Xiang‐Sun Zhang, Ling‐Yun Wu · 2018 · Scientific Reports
  66. Fumarate Upregulates Surface Expression of ULBP2/ULBP5 by Scavenging Glutathione Antioxidant Capacity
    Rikke Illum Høgh, Alec Droujinine, Sofie Hedlund Møller, Stine Dam Jepsen, Maiken Mellergaard, Lars Ole Andresen, Søren Skov · 2020 · The Journal of Immunology
  67. Mitochondrial Protein in the Nucleus
    Bor Luen Tang · 2015 · CellBio
  68. No evidence for the role of somatic mutations and promoter hypermethylation of FH gene in the tumorigenesis of nonsyndromic uterine leiomyomas
    Sireesha Vaidya, Noor Ahmad Shaik, Madhavi Latha, Srinivas Prabhu Chava, Mohammed Khaliq Mohiuddin, Annapurna Yalla, Kaipa Prabhakar Rao, Vijaya Lakshmi Kodati, Qurratulain Annie Hasan · 2012 · Tumor Biology
  69. Mechanistic Effects of Amino Acids and Glucose in a Novel Glutaric Aciduria Type 1 Cell Model
    Xi Fu, Hongjie Gao, Fengyan Tian, Jinzhi Gao, Liping Lou, Yan Liang, Qin Ning, Xiaoping Luo · 2014 · PLoS ONE
  70. The 2-oxoglutarate analog 3-oxoglutarate decreases normoxic hypoxia-inducible factor-1α in cancer cells, induces cell death, and reduces tumor xenograft growth
    Peppi Koivunen, Stuart M. Fell, Wenyun Lu, Joshua D. Rabinowitz, Andrew L. Kung, Susanne Schlisio · 2016 · Hypoxia
  71. Kidneys, Adrenals, and Retroperitoneum
    Ruth L. Katz, Savitri Krishnamurthy · 2008 · Elsevier eBooks
  72. A new missense mutation c.1240A>G in fumarate hydratase gene leads to uterine leiomyoma associated hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome in Chinese
    Li Wang, Ran Du, Lin Han, Rui‐Xu Yang, Yingxue Li · 2024 · Translational Oncology
  73. Immunometabolites and cancer: the role of 2-hydroxyglutarate, succinate, fumarate and itaconate in tumour development and anti-tumour immunity
    Thomas Pfefer, Anna Hanga Bessenyei, Luke A.J. O'Neill · 2026 · Immunology Letters
  74. Knowledge of hereditary renal cancer syndromes
    Jesús García-Donás, Susana Hernando, Nuria Romero-Laorden, Carlos Jara · 2010 · Anti-Cancer Drugs
  75. Molecular genetics of hereditary renal cancer: new genes and diagnostic and therapeutic opportunities
    Donna Elizabeth Hansel, Brian I. Rini · 2008 · Expert Review of Anticancer Therapy
  76. Racial disparity in metabolic regulation of cancer
    Pankaj K. Singh · 2017 · Frontiers in bioscience
  77. Isolation of circulating tumor cells based on magnetophoresis
    Ke Xu, Xue-Lei JIAO, Changyou Chen, Ping-Ping WANG, Chuanfang Chen · 2022 · Chinese Journal of Analytical Chemistry
  78. Fumarate Hydratase is a Novel Gene for Familial Non-Medullary Thyroid Cancer
    Ali Saeed Alzahrani, Meshael M. Alswailem, Balgees Alghamdi, Hindi Al‐Hindi · 2022 · The Journal of Clinical Endocrinology & Metabolism
  79. Mitochondrial Regulation of the Hypoxia-Inducible Factor in the Development of Pulmonary Hypertension
    Esraa M. Zeidan, Mohammad Akbar Hossain, Mahmoud El‐Daly, Mohammed A. S. Abourehab, Mohamed M. A. Khalifa, Ashraf Taye · 2022 · Journal of Clinical Medicine
  80. Metabolic Fluxes in Cancer Metabolism
    Ulrich L. Günther, Mei Chong, Tatiana Volpari, Katarzyna M. Koczula, Karen L. Atkins, Christopher M. Bunce, Farhat Latif Khanim · 2015 · Springer eBooks
  81. Aberrant expression of apoptosis proteins and ultrastructural aberrations in uterine leiomyomas from patients with hereditary leiomyomatosis and renal cell carcinoma
    Noel C. Wortham, N. Afrina Alam, Ella Barclay, Patrick J. Pollard, Bart E Wagner, Sanjiv Manek, George Elia, Ian P.M. Tomlinson · 2006 · Fertility and Sterility
  82. Obstacles in Renal Regenerative Medicine: Metabolic and Epigenetic Parallels Between Cellular Reprogramming and Kidney Cancer Oncogenesis
    Zsuzsanna Lichner, Fabrice Mac‐Way, George M. Yousef · 2017 · European Urology Focus
  83. Comparison of the effects of metformin on MDA-MB-231 breast cancer cells in a monolayer culture and in tumor spheroids as a function of nutrient concentrations
    Maruša Bizjak, Petra Malavašič, Sergej Pirkmajer, Mojca Pavlin · 2019 · Biochemical and Biophysical Research Communications
  84. Prolyl hydroxylase-3 is a novel renal cell carcinoma biomarker
    Kwang Hyun Kim, Hyung Ho Lee, Young Eun Yoon, Joon Chae Na, Kyung‐Sup Kim, Woong Kyu Han · 2019 · Korean journal of urology
  85. Genetic Factors
    Michael Francis Walsh, Karen Anne Cadoo, Erin E. Salo‐Mullen, Marianne E. Dubard-Gault, Zsofia Kinga Stadler, Kenneth Offit · 2020 · Elsevier eBooks
  86. USP39 regulates pyruvate handling in non-small cell lung cancer
    Tina Becirovic, Boxi Zhang, Helin Vakifahmetoglu-Norberg, Vitaliy O. Kaminskyy, Elena Y. Kochetkova, Erik Norberg · 2024 · Cell Death Discovery
  87. Fumarate Hydratase Restrains mtDNA Attenuates LPS-Induced Acute Lung Injury Through cGAS-STING Pathways
    Zewen Jiang, Ruyuan He, Yujian Zhong, Bohao Liu, Ziqi He · 2025 · Journal of Inflammation Research
  88. Hereditary Kidney Cancer Syndromes and Surgical Management of the Small Renal Mass
    Kevin A. Nguyen, Jamil S Syed, Brian M. Shuch · 2017 · Urologic Clinics of North America
  89. Clinical Significance of18F-fluorodeoxyglucose and Glucose Transporter 1 mRNA in Clear Cell Renal Cell Carcinoma
    Hironori Betsunoh, Setsu Sakamoto, Yasushi Kaji, Akinori Nukui, Minoru Kobayashi, Masahiro Yashi, Keitaro Hayashi, Naohiko Anzai, Takao Kamai · 2021 · Anticancer Research
  90. Isoform-specific Roles of Prolyl Hydroxylases in the Regulation of Pancreatic β-Cell Function
    Monica Hoang, Emelien M Jentz, Sarah M Janssen, Daniela Nasteska, Federica Cuozzo, David J. Hodson, Allan Russell Tupling, Guo‐Hua Fong, Jamie W. Joseph · 2021 · Endocrinology
  91. Depletion of Fumarate Hydratase, an Essential TCA Cycle Enzyme, Drives Proliferation in a Two-Step Model
    Balakrishnan Solaimuthu, Michal Lichtenstein, Arata Hayashi, Anees Khatib, Inbar Plaschkes, Yuval Nevo, Mayur Tanna, Ophry Pines, Yoav David Shaul, Yoav David Shaul · 2022 · Cancers
  92. Fumarate hydratase functions as a tumor suppressor in endometrial cancer by inactivating EGFR signaling
    Yen‐Yun Wang, Anupama Vadhan, Ching-Hu Wu, Cheng‐Yang Hsu, Yu‐Chieh Chen, Yuk-Kwan Chen, Pang‐Yu Chen, Hieu Nguyen, Yu-Chiuan Chang, Shyng‐Shiou F. Yuan · 2023 · Oncology Reports
  93. Fumarate and its downstream signalling pathways in the cardiorenal system: Recent insights and novel expositions in the etiology of hypertension
    Osaze Edosuyi, Ighodaro Igbe, Adebayo Oyekan · 2023 · European Journal of Pharmacology
  94. Zebrafish usp3 loss promotes hypoxic tolerance by disrupting deubiquitination of K63-polyubiquitinated hif-1αa
    Jun Li, Ziwen Zhou, Xiaolian Cai, Yanan Song, Zhi Li, Ziyi Li, Wuhan Xiao, Jing Wang · 2024 · Water Biology and Security
  95. DIAMMONIUM GLYCYRRHIZINATE INHIBITED INFLAMMATORY RESPONSE AND MODULATED SERUM METABOLISM IN POLY(I:C)-INDUCED PNEUMONIA MODEL MICE
    Yan Meng, Xuanlin Cai, Shan Cong, Jiao Sun, Wenjing Du, Huantian Cui, Li Luo, Xiumin Ma, Li Wang · 2024 · Shock
  96. Research Translation and Personalized Medicine
    James Brugarolas · 2012 · Springer eBooks
  97. Bioinformatics analysis and expression study of fumarate hydratase in lung cancer
    Zongjuan Ming, Meihua Jiang, Wei Li, Na Fan, Wenjing Deng, Yujie Zhong, Yuping Zhang, Qiuhong Zhang, Shuanying Yang · 2014 · Thoracic Cancer
  98. Oncometabolites as Regulators of DNA Damage Response and Repair
    Susan E. Gueble, Ranjit S. Bindra · 2021 · Seminars in Radiation Oncology
  99. Hereditary Leiomyomatosis and Renal Cell Cancer-Recognizing Patterns May Save Lives
    Catarina Tavares, Maria Sofia Quental, José Ricardo Brandão, Miguel Silva‐Ramos · 2022 · Journal of Kidney Cancer and VHL
  100. Familial Renal Cell Carcinoma
    Simon P. Kim, Bradley C. Leibovich · 2012 · Humana Press eBooks